Sanuwave Health Inc. SNWV

5.04 0.19 3.92% as of 25 Sep
Market cap
$41.7M
P/E
3.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
22.70 0.00 2.49 2.49 2.49 2.49 2.49 2.49 2.49 2.49
P/S ratio
5.80 3.15 1.42 1.42 1.42 1.42 1.42 1.42 1.42 1.42
P/FCF ratio
34.96 52.24 117.92 117.92 117.92 117.92 117.92 117.92 117.92 117.92
P/Operating CF
76.99 138.52 32.38 32.38 32.38 32.38 32.38 32.38 32.38 32.38
P/B ratio
157.84 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
6.03 3.61 2.17 2.17 2.17 2.17 2.17 2.17 2.17 2.17
EV/EBITDA
34.53 11.20 5.74 5.74 5.74 5.74 5.74 5.74 5.74 5.74
EV/Operating CF
68.51 47.98 148.15 148.15 148.15 148.15 148.15 148.15 148.15 148.15
EV/FCF
36.33 59.94 180.56 180.56 180.56 180.56 180.56 180.56 180.56 180.56
Quick Ratio
0.97 0.30 0.08 0.09 0.05 0.13 0.15 0.04 0.08 0.08
Current Ratio
1.38 0.41 0.15 0.11 0.08 0.22 0.20 0.07 0.11 0.12
Net Debt/EBITDA
1.30 1.44 2.85 (4.35) (1.24) (0.09) 0.11 (1.19) (0.03) 0.03
Debt/Assets
58.81% 84.24% 101.95% 72.54% 67.77% 19.39% 23.64% 460.12% 64.58% 4.72%
Debt/Equity
13.56 (1.61) (0.53) (0.35) (0.32) (0.33) (0.08) (0.35) (0.08) (0.01)
Asset Turnover
1.31 1.24 0.96 0.87 0.62 0.31 0.45 1.51 0.65 1.40
Operating CF/Net income
0.33 (0.07) 0.18 1.67 0.24 0.41 0.61 0.31 0.28 0.50
Capex/Depreciation
1.25 (0.07) 0.00 0.06 (0.12) (0.04) (0.76) (0.01) 0.00 (0.02)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(166.66%) 112.20% 61.31% 25.74% 103.50% 260.18% 82.06% 92.18% 65.96% 100.69%
ROA
35.02% (125.95%) (122.05%) (53.48%) (130.91%) (234.29%) (457.48%) (946.99%) (484.99%) (655.94%)
ROIC
26.60% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
134.97% 123.80% 47.76% 19.52% 53.61% 111.38% 106.24% 75.89% 55.97% 92.98%
Average Days of Receivables
44.93 37.23 59.30 87.84 67.75 211.96 26.79 46.32 75.37 122.22
Research and Development Expense of Revenue
3.07% 2.06% 2.84% 3.39% 8.46% 30.71% 114.89% 53.06% 175.02% 82.01%
Selling, General and Administrative Expense of Revenue
60.82% 58.96% 66.54% 119.64% 155.89% 465.44% 780.70% 396.34% 406.82% 194.30%
Intangible Assets out of Total Assets
0.28 0.36 0.52 0.62 0.70 0.60 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
11.01% 4.64% 1.10% 5.30% 0.00% 64.41% 35.18% 188.70% 129.86% 56.52%
Graham Net Nets
(0.04) (0.27) (1.74) (1.74) (1.74) (1.74) (1.74) (1.74) (1.74) (1.74)
Graham Number
2.36 23.58 71.41 66.12 110.45 94.38 87.02 155.68 93.37 109.05
Earnings Yield
4.40% (30.35%) 40.22% 40.22% 40.22% 40.22% 40.22% 40.22% 40.22% 40.22%
Free Cash Flow Yield
2.86% 1.91% 0.85% 0.85% 0.85% 0.85% 0.85% 0.85% 0.85% 0.85%
Revenue per Share
5.14 7.31 9.64 11.28 9.30 3.97 1.87 4.58 1.97 4.74
Operating CF per Share
0.45 0.55 (2.14) (11.57) (4.58) (12.46) (11.66) (8.97) (4.08) (11.01)
Capex per Share
0.40 (0.11) 0.01 0.22 (0.38) (0.05) (0.10) (0.11) 0.00 (0.03)
Free Cash Flow per Share
0.85 0.44 (2.13) (11.35) (4.96) (12.51) (11.76) (9.07) (4.08) (11.04)
Cash per Share
1.40 2.29 0.85 0.78 0.44 2.39 3.20 0.90 1.95 0.46
Shareholders Equity per Share
0.19 (3.54) (20.40) (27.64) (27.84) (13.44) (18.31) (38.03) (26.36) (23.78)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.19 (3.54) (20.40) (27.64) (27.84) (13.44) (18.31) (38.03) (26.36) (23.78)
Free Cash Flow
7.31 1.97 (4.52) (16.84) (6.94) (12.77) (6.46) (3.66) (1.53) (3.21)
Working Capital
6.78 (27.03) (54.97) (53.59) (51.86) (28.25) (9.91) (15.40) (9.96) (7.00)
Capital Expenditures
3.43 (0.49) 0.02 0.33 (0.53) (0.05) (0.05) (0.04) — (0.01)
Net Current Asset Value
(11.10) (27.52) (55.81) (54.26) (53.18) (28.82) (10.94) (15.45) (9.96) (7.00)
EV/EBIT
53.70 30.61 16.16 16.16 16.16 16.16 16.16 16.16 16.16 16.16
Capex to Sales
(0.08) 0.02 0.00 (0.02) 0.04 0.01 0.05 0.02 0.00 0.01
Net Profit Margin
26.82% (101.38%) (126.52%) (61.48%) (209.52%) (762.56%) (1,013.88%) (628.69%) (749.88%) (467.92%)
Price to Operating Income
51.68 26.68 10.55 10.55 10.55 10.55 10.55 10.55 10.55 10.55
Other line items
Depreciation/Fixed assets
1.39 22.00 8.46 6.89 4.41 3.18 0.76 37.79 9.36 7.59
Cash ROIC
5.36% 10.86% 29.56% 70.85% 28.85% 193.47% 86.69% 38.64% 19.09% 48.68%
Accounts Receivable Turnover
10.07 9.83 5.56 5.20 5.45 3.34 6.63 9.55 2.41 5.14
Accounts Payable Turnover
2.89 1.71 1.19 0.72 0.82 0.39 0.36 0.45 0.22 0.92
Inventory Turnover
2.00 2.28 3.16 4.54 2.50 0.66 1.20 2.35 1.04 2.19
Average Days of Payables
117.70 168.32 345.04 370.82 559.58 1,399.06 974.91 837.97 2,257.12 460.53
Days of Inventory on Hand
214.83 187.33 178.48 73.15 76.13 928.52 367.78 188.26 349.16 149.85
Average Receivables
4.38 3.32 3.67 3.22 2.39 1.22 0.16 0.19 0.31 0.27
Average Payables
3.49 4.72 5.05 6.02 6.05 2.95 1.52 1.54 1.10 0.61
Average Inventory
5.04 3.55 1.91 0.95 2.00 1.75 0.45 0.29 0.23 0.26
Average Assets
33.73 26.27 21.14 19.25 20.82 13.20 2.28 1.23 1.14 0.98
Average Common Equity
(7.09) (29.49) (42.09) (39.98) (26.34) (11.89) (12.71) (12.62) (8.40) (6.39)

Fold the line items

Columns are period end dates